Skip to main content

Specialty Pharmacy

  • 21st Century Cures Act passes Senate, heads to Obama’s desk
    WASHINGTON — The Senate voted 94-5 on Wednesday to pass the 21st Century Cures Act, sending it to the desk of President Barack Obama. The act, which was passed by the House of Representatives on Nov. 30, includes funding to support the fight against prescription drug abuse and funding for the National Institutes of Health’s cancer initiative, known as Vice President Joe Biden’s “cancer moonshot” initiative, which was renamed by the Senate after Biden’s son, Beau, who died of cancer in 2015. 
     

  • Diplomat unifies infusion companies under new Diplomat Specialty Infusion Group
     
    FLINT, Mich. — In an effort to bring together its five infusion subsidiaries, Diplomat Pharmacy launched its new brand, the Diplomat Specialty Infusion Group. The brand unites American Homecare Federation, At-Home IV Infusion Professional, BioRx, MedPro Rx and XAS infusion services. 
     

  • McKesson's Pharmacy Optimization team identifies 5 key pharmacy trends headed into 2017

    LAS VEGAS — The implications the new Trump administration will have on healthcare isn't the only trend that has pharmacy executives abuzz. In fact, the McKesson Pharmacy Optimization team, a group of trusted advisors who work to help elevate the value of health system pharmacies, has identified the top five trends that will impact hospital and health system pharmacies in 2017.

  • Diplomat to dispense Darzalex
    FLINT, Mich. — Diplomat Pharmacy will be dispensing Janssen’s Darzalex, the company announced Thursday. The drug will be dispensed in combination with Revlimid (lenalidomide) and dexamethasone or with Velcade (bortezomib) and dexamethasone. 
     
    The drug was approved by the Food and Drug Administration to treat multiple myeloma in patients who have received at least one other treatment. 
     

  • Amber pharmacy tops Zitter Health Insights survey in satisfaction
    OMAHA, Neb. — Employees of Hy-Vee’s specialty pharmacy subsidiary, Amber Pharmacy, came out on top of a recent patient satisfaction survey conducted by Zitter Health Insights. After asking some 3,000 patients at 38 American specialty pharmacies, Amber Health’s nurses, pharmacy technicians and billing department earned scores of 100% and their customer service representatives scored 95%. 
     

  • Report: Walgreens opens latest 'Community' specialty banner in Ohio market

  • J&J, Actelion Pharamceuticals confirm early talks for reported potential acquisition
    NEW BRUNSWICK, N.J. — On Nov. 25, Bloomberg reported that Johnson & Johnson and Actelion Pharmaceuticals were in discussion over a potential acquisition of Actelion by J&J. Both companies have confirmed that they are in preliminary discussions. 
     

  • Diplomat to dispense Cuvitru
    FLINT, Mich. — Diplomat Pharmacy announced Monday that it had begun filling prescriptions for Shire’s Cuvitru, which launched last week following its September approval by the Food and Drug Administration. The drug treats primary humoral immunodeficiency in patients ages 2 years and older. 
     
    "We are excited to offer patients a therapy that expands their options for treating primary immunodeficiency," Diplomat president Paul Urick said. "Cuvitru is an important treatment for patients with unmet needs."
X
This ad will auto-close in 10 seconds